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plasma Iov~ls of tntefleukin (IL) 2, 6 ar¢110, eylokinos which are ablo to affect 
LYMPHO fun~lon and In m0dulato inflammatory proees~u~s, 
Meffmds: Threa groups of pts were studi~: 42 pIS w~m (Idmifted to 
the CCU 13~u~ of on acute lr~tmm~¢ Sy~lrome (AIS group), 36 pie had 
stable ongtna (SA group) and 39 were healthy control subJ(~'ts of equivalent 
age (CTL group), To cl~ra~e~e LYMPHO pbenoM~, flow o/lOmetry was 
pef fO~ in whole, bi0od gmplas ~ l  marx:lanai ~fltibo~te~, IL~, IL.6 
and IL-10 were measured umng ~ ELISA method 
Result" No d ~  was found amtortO lt~e 3 OrO~ l~ the expression 
of C02, C03, CD4, CDa, C019 e~t¢l HLADR m~plom, Double ~nd mple 
ev~ualmn ~t~ an i ~  in C00+C0111~ ~ells (ojlolo=¢ 
T LYMPH<)) a~d in CO16t~O56~COttt~,cetl~ (NK LYMPHO) in tt~ AI$ 
group M~I in ~A OtoUp aS ¢!m~pamd to the CTL group (CD~-CDIlb-*: A!S 
? ~ _2~/~, ~ 0-~ • 1%, c'rL 4,! ± 1%, p ~ 0-05: CDAI~CO~CD!1b*  
AI~ 19,8 :~ 2,3%, SA ~_1.5 ~ !,6%, CTL 6`6 :L 12%, p .~ 0.001), 
W~lhout a~t~tcaity s ~  ~f t~ between A!S at~l SA (;FofllP~- IL-2 
w~ ino, ea~l  in the AtS and SA gn~ aS compared to the CTL group (AIS 
,5.7 ~: O.fl, ~,A 6-5 ± 1.4, CXL ~,4 ± 0,4 pg/ml, p ~ 0.01), whereas Ik.6 WaS 
higher' m tt~ A!S gm~pth#n i  It~ olttm ;~ ~ (AIS 10.8 * 1,?., ~32 ± 
0-,5, CTL ~,0 p ,. 0001). No = t ~  was tour~! between the 3 g ~  m 
the p ~  ~ of !L,t0. 
(~tlCA~:i~tl: These data show II1al ~ wllh ische~ heart disease ha~,e 
an l ~  in eimutalmg cytotot¢ LYMPHO and in IL.2 plasma tewelS as 
~red  Io natural L"(~trOI Stdl~lects. IL'6 =s increased (~ly in pls ~ AIS, 
~ le l tmminuda as a IP~edictor of Coronary  Ar tery  
KR Tuftle, ME. PuNman, S-K. Cooney, LR  Oahtstrm~, T.E. Can~en, 
R~ She~ The Heart Instate at Sp~ane, Spo~t~. Was~mjton, USA 
re,ales to measurable coronan/artery (#rsease (CAD) has not 
been detem~ed. 
/I,~--~=,,~. - In 308 ~ e  patients, u n ~  eleclwe comnaqf on- 
g~:jtald~, alt~mn (RIA) and cma~nine (mo~F~ed JalYe nm) were measured 
m urine lrom an early morning void. The albumin to c,eatimne rafm (ACR) 
wa~ calculated. Fasting plasma msulth (RIA) was n'~asured. Seventy of CAD 
was delemdned by standard ang~jraphtc m~a 
ResuP~: 11~ ACR was 28 ~ 5 in patiertts wffh CAD (n = 242), and 10 _ 1 
in those wdhout CAD (n = 66). p < 0.001. In patmnts ~ (~abeles and CAD 
(n = 37) the ACR was 64 ± 20, cotllpared to 22 ± 4,1 non-dklbe~cs 
CAD (n = 205), p = 0056. Se~ of CAD was related to ACR and insu(in: 
CAD Nag In = 645) I~k::l In = 131 MOd In = 70"1 Severe In = 1591 
ACR (rrg~g) 10 ~: 1 17 = 6 25 • 7" 31 ¢ 6" 
Ir'-c~u~n I~,U.'r~L) 13 : 1 12 ± I 15 ~ 2 24 ~ 4 "? 
Means ~. SE "p * 005vs nego~ r~ld: tp .  005v~ mad 
The odds ratvo (OR) for mcderate or severe CAD was 2.5 (95% C! 1.1-5.6, 
p < 0.05) in those with "mnary albumin >20 moJL: the OR was 2.9 (95% C| 
1.5,--5.9. p < 0.05) if insulin was also >16 .U/mL 
Conc/us/o~s: The presence of CAD and rts seventy is hvghly correlated 
with urinary albumin. The effect LS even greater in diabetes. MA~ with or 
without hyperinsulinemia, presets a high ask of clinK:ally s~gnificant CAD. 
[ • - •  Myocardial Perfusion Before Single and After 
Routine LDL-Apheres is  
C. Meyer. H.C. Geiss. C.S. Duvemov. K.G. ParhoteL P. S.Chw~Ln~U 
~? o~MWal~t: c~n~bnlT/l~i~tlS Of, ver'3;~ lLr'crfn~a/U~lversl~ M~ImCh. 
Germany 
Background: Lipid Iowenng therapy may improve corenaw vascular funcITon 
by a direct vascular effect of lipid concentration. 
Methods: We investigated the acute effect of a single LDL-apheresis 
(LDL-A) on myocardial pertusion by measuring myocardial bleed flow (MBF 
in ml/min/g) with N-13 ammonia/PET at rest and vasodilatory capacity dunng 
adenosine hyperemia (140 mg/koj'min for 5 rain,) in 10 patients (6 F/4 M) 
with heterozygous familial hypercholesterolemia (FH) and CAD treated with 
weekly LDL-A for 2-10 years. Patients were studied before and after LDL-A; 
each was randomly assigned to PET scan shortly before LDL-A and again 
one day later, or to PET scan just after LOL-A and again prior to LDL-A the 
following week. 
Results: see table. All values are mean ± SD 
The rate-pressure-product remained unchanged at rest and during adeno- 
sine. AlthouQh LDL-A induced a reduction of LDL-Cholesterol by 45%, pa- 
rameters of MBF remained unchanged. 
S(.an I ~n 2 p-v~e 
TotabChol 235 x 3,3 I~9 ~- 18 -0000001 
LOl=~hol 166 ~z 14 ~1~, x 9 ~000(~01 
M~F~,~ 0.88 • 0 31 0 79 ~: 020 ns 
MBF~mo=~e ~48 ~ 0~8 ~2t ~: 082 ns 
CFR ~§9± t 14 ~74 ±076 n~, 
has no instant 0ftect on myocardial r~rlku~n and vasoddatow r, ZK~IIy m 
pat~ w~n FH freat~ w~ wa~y kl~-^. 
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~ N ~ w  Therapeutic Poulb!llty for  ~ l s  A f t~ 
AngloplasW by Inhibit ing Pml l t~ l~/mMne 
~ho~/ l l l l lm of  Focal Adhe l lon  Klmme and 
PmlHlin 
K Miyosh~, V. Nozawa~ E Sasaki, H Terakawa. N Od l  Y Tanahasf,, 
Y. Yamasaki, Y. Murat~zka, H. Mh/aka, N. Ma~uur~L TattOo Ptmtmaoeutcal 
~ of smoom muscJe cegs (SMC) ceumng neomema ~ ~ 
known 1o be ( ~ .  on p~olefn-tyresine ~ (PTP) of focal 
TAS-30I, ,3~~Jmethy /ene-2~inone,  on FAK actlon m 
neomt~ma fonnalmn attar ~ mlmy In a rat balloon m~uly model, oral 
al~icalmfl of TAS-3OI s@11ficanfly reduced the number of Oa0s that migrated 
to llm lumen surface (at 100 m~,  50 ~ 5 (SD) ve. 95 :t: t5c~,  P < 
0.01) and the ratio of ml~ma ~ area ina d o ~  mlz, lx1~. 
In a modified Bo~n chamber a~aay, TAS-301 do~- ,x3~, -ay  intifll~ed 
ttte mKjratmn of rat Fg~lCinmspormetoPDGF.BB(at 3pM.65 ± 30,m 146 
± 14 ceg~4HPF, p < 0.01). Western blot ana~ with a n ~ n e  
antlt~,dy ~ that TAS..301 at 10 pM Inhd~led PTP of FAK (0.81 ± 0.12 
vs. 122 :~ 0.22-fold increase agaJnsl the control level, P < 0.05) and of 
ipaxillin (2.4 ¢ 0.7 vs. 4.4 ± 0.9, P < 0.01), ~ not that of PDGF-p r~or ,  
in rat SMC sllmulated by F~GF-BB. 
These data su~ that PTP of FAK and paxillin Ls a causally related to 
the migration phase of SMC du~ neo=r~ma formalin, n. and also s~gest 
ff~e r~w therapeubc poss~blltty ofTAS-301 for mslenosvs after angloplasty 
~ Function and Expression of 
Endofhelin~onverflng Enzyme-1 in Human 
Vascular Smooth Muscle 
F. Rusch~tzka, G. Nail. M. Lachat 1 , S. Sl~aw, "rE Lds~.dler. C ,a~,  
Can~iovascu/ar Research anal Institute Of Phy~,  Switzerland: Y C&dmc 
Surgery. University Zurich. S~tzedand 
Back~z:~:/: I~  ondothelin-1 (big ET-I) ~s coflverled to en~othattT~l by en- 
dotheltn co~wertmg enzymes OECE). previous sludies suggested that this 
conversion can be inhibited by the metalloprotease tnhll~for I~mi -  
don. 
Methods: Funct~ot~at ECE actnnty was studt~:l in isolated human arteries 
,/.,nZen~ I m~mmap,.P, .,;~,, ~ ~ ~,~'.~,t~p,,. P~ ~'ve~r~ ~,taw~mwe~, 
SV) in organ chambers. Express~on of ECE-1 was analyzed by RT-PCR in 
cultured smooth muscle cells. 
Results: Big ET-1 (1-100 nrnat/L) mo'ucad srmila~ contracllons in SV with 
(+E) or wdhout endothelium (-E) (+E: 62 ± !P/= of KCI; -E: 58 ± 7%; n = 
7), which were sK:jnificantly reduced (Out not prevented) by the ECE inhib,~or 
phospheramidon (0.1 mmol/L) (+E: 31 + 7%; -E" 27 ± 8%; p < 0,05 vs 
controls; +E./-E: n.s.), Big ET-I induced simdar responses in IMA (+E: 58 ± 
9%; -E: 51 :~ 9%: n = 7). In contrast, contractions were higher in RA (+E: 77 
± 9%; -E: 68 ± 10%: n = 7; p < 0.01 vs controls). While phosphommidon 
attenuated big ET-1 contractioP.s in IMA (+E: 40 ± 9%; -E: 38 ± lf%; p < 
0.05 vs controls), it did not affect responses in RA (+E: 79 ~ 8%; -E: 70 
+ 12%). ET-1 tissue content was significantly elevated in RA and IMA (p < 
0.001 vs SV). ECE-1 m.RNA could be detected in vascular smooth muscle 
cells of all arteries and veins investigated. 
Conclusions: These data demonstrate that (1) big ET-1 induces endethe- 
lium.indeper,~=mt contractions in human vessels and that (2) conversion of 
big ET-1 to ET-I is mediated by phosphoramidon-sensitive and insensitive 
~q.,%. -~Wlm-a~y :'n, -s'nlt.~ ~ -n~J~ ~:",~- '-Fi~'c~, " , "~ '~'~'~'~,~ `Y~&~'~=Cz~ 
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ECE.Inhlbltors provide an effective approach to pharmacologically block lho 
effects of endothelln in mnn, 
• Differential Effects of Protsmlne on Conductance 
and Resistsnce Arteries: Evidence of 
Hyperpolarlzlng Factor (EDHF) Release 
D,G, Cable, M,R, OeltJen, H.V, Scheff, M~yo Clinic end M~yo Foundaflen, 
Rochester, Minnesota, USA 
Background: Protamlno revorael of heparln may I~d to systemic hypoten. 
~lon eeeend~¢Y to endothellel nitric oxide (NO) mle~lse, Endothollum.derlvod 
hypsq0olerl;¢lng feeler (EDHF) Is a novel footer olessed by the ondothsltum 
The prOllOnt study compared the roleelln of vasoncllve substances from 
remten~a (100=,?.00 .m) and oonductnn~o erterles, 
Method# fmcl Results; Canine mnlstnnce comne~/~rtertes wan meunted 
In a vl~eesceple no.flow miomvassol system, end paired ~Imumflox coronnw 
arteries were studied in organ ehembem', both war0 oontragted with endotho. 
Iin.1, Pmfemlne (10-60 mgm/ml) predated rolexatlenn in both mlcmveasel 
end ¢ondu(~tence aderles (n '~ 10); maximum mlaxatlen wee 46,0 ;L 13,0% 
In re=lslnnce v~ 94,3 ~ 8.2% in conductance ndarles, Removal el the an. 
d0thellum ~boltshed relaxations to profemlno (n = B, P -. 0.05, ANOVA), 
tndomathn¢~ln (10 ~SM) did not attar rah~xetions; 462 ~. 8,5% vs 103.1 t 
?,.'1% (n = 6), L.NMMA (10 '~M) had na sheet In resistance aderies (575 
9,g%, n =, El) but attanunted ~olnxetlons incondu(~fan~e artertea (38,3 
12,0%, n ~ 8, P • 0,05), Tetmethylemmentum (chloride (TEA, 10 "~M), an 
inhibitor of ~DHF, abolished mlexattent~ n msts~en(~n arteries but had no 
effeC:t OI1 oonductenca rtertns (103,2 :t~ ~),0%, e ~ 0), Miomvease~s produced 
only mild Qentraotlens to prot0~mtno Inthr~ presence o1 TEA (max contraction 
24,5 ~l 11,4%, n ~ 6, P ,: 0,05), 
Conclusions: Pmtamlne sulfate ~eusos ond0thollum-depondent relax- 
allen of conductance adartes and mstMance edorles by different mecha- 
nisms; NO intense in large npicerdtnl vessels and EDHF release in mi. 
cmvessels, Thl~ Is the first description of EDHF release in response to 
pmtemine, As EDHF can be blacked with cnrdloplogi¢ arras1, protamine may 
generate malone1 Imbslan~:os in myocardial podus~en due to the dilation el 
conducten~'-e v ssels end concurrent constnctlon of resistance arteries, 
• Vascular Smooth Muacle Cell Proliferation 
Induced bythe Interactlon Between Serotonln 
(5H1") endMlldty Oxldlzed LOW Denslty 
Llpoproteln, laRevereed by 5HT= Receptor 
Antagonlst or Pertuasls Toxin 
S Keb~, R. P,~kela, 1". Katagm, C.R. Benedict. University of Texas, Houston. 
TX, USA 
Background: We have previously shown that mildly oxidized low density 
lipoprotoln (mox-LDL) induced vascula[ smooth muscle cell (VSMC) preht- 
eralion nnd this effect was potentiated by 5HT, We examined the pos~ible 
mechanisms for those effects. 
Methods: Growth arrested primary rabbit VSMC were incubated with 
different concentrations of LDL or mox-LDL in the presenco or absonce at 
pertussls toxin (PTX, 10 ng/ml) for 24 hrs, to,owed by incubation with 5HT (50 
.M) or with 5HT (50 ~iM) + 5HT~ receptor antagonist (LY281067, 10 ~=g/ml) 
for 24 hrS. Then 3H-thymtdine incorporated into the DNA was measured. 
Results: Beth LY 281067 and PTX reversed the mitogenic effect of 5HT, 
and the synergistic interaction between 5HT and LDL or mox-LOL on VSMC 
proliferatien. 
f ~ Control i 400 ~ SHT 






0 LDL 60~g/ml moxLDL 60%9/ml 
Conclusion: These results suggest that a 5HT2 receptor nntegonlst fLY 
281067) can prevent ff~o proliferative ffect of 5HT and its interaction with 
LDL or mox-LDL on VSMC at sites of vascular damage. 
~ Hlrudln Don Not Prevent Platelet ActlvaUon In 
Heperln Induced Thrombooytopenlc Syndromes 
D, Famed, J, Famed, L, Yang, D, Hoppansteedt. W, Jeske, S, Haas, 
H, Messmom, Loyola University Medical Center, Maywood, IL, USA, 
Technical University of Munich, Munich, Germany 
Rncombinenf hirudln (r.H) is approved for the anticoagulant management of 
pettante with heperin induoed thmmbocytopenia (HIT), De~pito the u~o of 
potent anticoagulant drugs the modnlity rate in patients with HIT and HIT 
with thrombosis romaine high, Initial sit=dies have indicated that o~o the 
antibody mediated salivation of pletelets has storied, himdin fails to inhib,t 
the process, To investigate this affect, blood was drawn from 30 human 
VOhlntoom in htmdtn (10 i~gtml) and 3.8% citrate, Whole bloocl impedomot~t 
nnd pletelot aggregation studies were carried out using a Ix~itivo HIT serum 
pool prepared from 20 clini(~elly established HIT positive p~tiente In both the 
~ltrated and hffudini=od blood systems a strong activation ot platelnts was 
observed, Hirudin also foiled to block the ATP release from ptatetets ulx~n 
the HiT sarum/hnpenn ec;tivetien. Similarly, in the flow ¢yt0mofno studies pa. 
tionts with established HIT syndrome c;olloctod in Citr~ted 0t himd!n exhibited 
strong ~atJvetion Supplementation ofg!ycopmtein lib/Ilia receptor mhibitom 
such as ReoPro, at sublherepo(~ti~ levels (05 i~g/ml), totally inhibited the 
HiT serum induced activation at platelats. The synlhcttc GP Ilbilga inhibitive 
else Inhibited tho activation of hirud=n nl~coagulated plat0tets. These obser. 
vations clearly suggest while hirudin may provide strong anticoagutation, it 
is of limited va!uo in tho acute phase of HIT. Antiplatelet drags such as GP 
lib/Ills inhibltora may be useful in the management el such cases 
~ Effects of Phytoestmgens on Precontrected 
Rabbit Coronary Arteries 
G.A. Fqgtmo, Y..Q. Lu, P. Coffins. Imperial Co#ego of Science, Technology & 
Medicine, NatPonal Heart & Lung In.qfihlto, London, UK 
Interest n the vascular properties of phytoostrogens ts mcmastr~j, however 
their effects or' coronary srtenas am largely unknown. We theretore investi- 
gated tho vasoactive properties of the phytoestrogons genislein (G), phlomtin 
(P) and biochanm (B) on rabbit coronary artenes in wtro. Epicardial coronaq/ 
artenal nngs of male and female rabbits were suspended in organ loathe 
lor measurement of changes in isometric tension. G (10, 20. 40 .mot~_) 
induced significant relaxation of coronary artenal nngs precontracted w~th 
potassium (30 raM) m a dose-dependent manner (mean ~: SEM: 13 ~ 1.48 
:'c 3 and 100 t 3% respectively, P .  0.01). as did P (5, 10. 20, 40 ~moL'L: 
11 ± 1, 30 ~ 2, 66 ~ 2, 97 ~ 3°o), and B (1.3. 10 and 30 .reel/L; 3 ~. 1, 
12 r I, 55 ~ 4, 103 ~ 3%). There were no differences between arteries 
from male or female rabbits, with or w~thout endothelium L-NAME and ln- 
doree[hacm did not affect phytoestrogen-induced mlaxahen in nngs with an 
intact ondothellum. Glibenclamide, banum chlonde and mehtylene blue had 
no effect on phytoestrogen-induced relaxation in nngs without endothelium. 
The specific estrogen-receptor antagonist ICI 182, 780 did no1 affect the 
coronary relaxation induced by any of the phytoestmgens. Calcium conoen- 
tralion-depende~,[ contraction curves (4, 3.,5.3. 2.5 and 2 .log M calcium) m 
K ~ depolarization medium were shifted to the right after incubation wilh G 20 
.mot/L (19.3 :~ 1, 47 ± 3.1, 62 ± 2.9, 81 ± 3.3 and 88.2 ± 43% contraclton 
respectively; P .  0.001) and 40 .mob'L (7.6 ± 0.6, 18.4 ¢ 1.2, 327 ± 3.2, 
602 ± 4 and 73.3 ~ 33% contraction respectively; P ~ 0.001) in nngs with- 
out endothehum compared to control (41.2 ± 2.7, 67 ~- 1,8, 81.8 ± 1.1.98 
1.3 and 100 ~- 0% contraclton respectively). Maximal contraction was also 
reduced. We have demonstrated that the phytoestrogens genistein, phlorelln 
and biochanin induoe signilicanl, endolhelium-independent relaxation in iso- 
lated rabbit ooronary arteries. The mechanism may involve antagonism of 
calcium channels. 
~ Ab¢iximab Inhibits Release of Platelet Granule 
Constituents 
MA. Mascelli. S.J. Marciniak, ET. Lance, R.E Jordan. Centocor, Inc.. 
Malvern, PA, USA 
The effect of abciximab tc7E3 Feb, ReoPro TM) on agonist-induced platelet 
granule release (PGR) was studied, Platelet rich plasma from normal donors 
i n = 3) was treated with abciximab for 5 rain at 37°C. The platelets were 
then stm~ulated with either TRAP or ADP and aggregation was monitored 
for 4 min. ATP release was monitored during aggregation by chemi-lumi- 
nescence. After aggregation, platelets were treated with inhibitora to block 
further release, then lhe ptasma was collected, t~-thromboglobulin (tt-TG) 
and plasminogen activator inhibitor 1 (PAl-l) plasma levels were measured 
